The latest research study released by Market IntelliX evaluates market size and forecasts of Artificial Intelligence in Medical in Global, including the following market information:
Global Artificial Intelligence in Medical Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Artificial Intelligence in Medical market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hardware Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Artificial Intelligence in Medical include AstraZeneca, Thales Group, IBM Corp., ForeSee Medical, Atomwise, Cloud Pharmaceuticals, GNS Healthcare, Microsoft Corporation and Novartis AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Artificial Intelligence in Medical companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Artificial Intelligence in Medical Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Artificial Intelligence in Medical Market Segment Percentages, by Type, 2021 (%)
Hardware
Software
Global Artificial Intelligence in Medical Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Artificial Intelligence in Medical Market Segment Percentages, by Application, 2021 (%)
Diagnosing Diseases
Developing Drugs
Personalized Treatment
Other
Global Artificial Intelligence in Medical Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Artificial Intelligence in Medical Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Intelligence in Medical revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Artificial Intelligence in Medical revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
AstraZeneca
Thales Group
IBM Corp.
ForeSee Medical
Atomwise
Cloud Pharmaceuticals
GNS Healthcare
Microsoft Corporation
Novartis AG
NVIDIA Corporation
Pfizer
Recursion Pharmaceuticals
XtalPi Inc
Aidoc
AliveCor
GE Healthcare
Imagen Technologies
Vuno Inc.
IDx Technologies Inc.
Siemens Healthcare GmbH
Neural Analytics
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Artificial Intelligence in Medical Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Artificial Intelligence in Medical Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Artificial Intelligence in Medical Overall Market Size
2.1 Global Artificial Intelligence in Medical Market Size: 2021 VS 2028
2.2 Global Artificial Intelligence in Medical Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Artificial Intelligence in Medical Players in Global Market
3.2 Top Global Artificial Intelligence in Medical Companies Ranked by Revenue
3.3 Global Artificial Intelligence in Medical Revenue by Companies
3.4 Top 3 and Top 5 Artificial Intelligence in Medical Companies in Global Market, by Revenue in 2021
3.5 Global Companies Artificial Intelligence in Medical Product Type
3.6 Tier 1, Tier 2 and Tier 3 Artificial Intelligence in Medical Players in Global Market
3.6.1 List of Global Tier 1 Artificial Intelligence in Medical Companies
3.6.2 List of Global Tier 2 and Tier 3 Artificial Intelligence in Medical Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Artificial Intelligence in Medical Market Size Markets, 2021 & 2028
4.1.2 Hardware
4.1.3 Software
4.2 By Type - Global Artificial Intelligence in Medical Revenue & Forecasts
4.2.1 By Type - Global Artificial Intelligence in Medical Revenue, 2017-2022
4.2.2 By Type - Global Artificial Intelligence in Medical Revenue, 2023-2028
4.2.3 By Type - Global Artificial Intelligence in Medical Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Artificial Intelligence in Medical Market Size, 2021 & 2028
5.1.2 Diagnosing Diseases
5.1.3 Developing Drugs
5.1.4 Personalized Treatment
5.1.5 Other
5.2 By Application - Global Artificial Intelligence in Medical Revenue & Forecasts
5.2.1 By Application - Global Artificial Intelligence in Medical Revenue, 2017-2022
5.2.2 By Application - Global Artificial Intelligence in Medical Revenue, 2023-2028
5.2.3 By Application - Global Artificial Intelligence in Medical Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Artificial Intelligence in Medical Market Size, 2021 & 2028
6.2 By Region - Global Artificial Intelligence in Medical Revenue & Forecasts
6.2.1 By Region - Global Artificial Intelligence in Medical Revenue, 2017-2022
6.2.2 By Region - Global Artificial Intelligence in Medical Revenue, 2023-2028
6.2.3 By Region - Global Artificial Intelligence in Medical Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Artificial Intelligence in Medical Revenue, 2017-2028
6.3.2 US Artificial Intelligence in Medical Market Size, 2017-2028
6.3.3 Canada Artificial Intelligence in Medical Market Size, 2017-2028
6.3.4 Mexico Artificial Intelligence in Medical Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Artificial Intelligence in Medical Revenue, 2017-2028
6.4.2 Germany Artificial Intelligence in Medical Market Size, 2017-2028
6.4.3 France Artificial Intelligence in Medical Market Size, 2017-2028
6.4.4 U.K. Artificial Intelligence in Medical Market Size, 2017-2028
6.4.5 Italy Artificial Intelligence in Medical Market Size, 2017-2028
6.4.6 Russia Artificial Intelligence in Medical Market Size, 2017-2028
6.4.7 Nordic Countries Artificial Intelligence in Medical Market Size, 2017-2028
6.4.8 Benelux Artificial Intelligence in Medical Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Artificial Intelligence in Medical Revenue, 2017-2028
6.5.2 China Artificial Intelligence in Medical Market Size, 2017-2028
6.5.3 Japan Artificial Intelligence in Medical Market Size, 2017-2028
6.5.4 South Korea Artificial Intelligence in Medical Market Size, 2017-2028
6.5.5 Southeast Asia Artificial Intelligence in Medical Market Size, 2017-2028
6.5.6 India Artificial Intelligence in Medical Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Artificial Intelligence in Medical Revenue, 2017-2028
6.6.2 Brazil Artificial Intelligence in Medical Market Size, 2017-2028
6.6.3 Argentina Artificial Intelligence in Medical Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Artificial Intelligence in Medical Revenue, 2017-2028
6.7.2 Turkey Artificial Intelligence in Medical Market Size, 2017-2028
6.7.3 Israel Artificial Intelligence in Medical Market Size, 2017-2028
6.7.4 Saudi Arabia Artificial Intelligence in Medical Market Size, 2017-2028
6.7.5 UAE Artificial Intelligence in Medical Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Artificial Intelligence in Medical Major Product Offerings
7.1.4 AstraZeneca Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca Key News
7.2 Thales Group
7.2.1 Thales Group Corporate Summary
7.2.2 Thales Group Business Overview
7.2.3 Thales Group Artificial Intelligence in Medical Major Product Offerings
7.2.4 Thales Group Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.2.5 Thales Group Key News
7.3 IBM Corp.
7.3.1 IBM Corp. Corporate Summary
7.3.2 IBM Corp. Business Overview
7.3.3 IBM Corp. Artificial Intelligence in Medical Major Product Offerings
7.3.4 IBM Corp. Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.3.5 IBM Corp. Key News
7.4 ForeSee Medical
7.4.1 ForeSee Medical Corporate Summary
7.4.2 ForeSee Medical Business Overview
7.4.3 ForeSee Medical Artificial Intelligence in Medical Major Product Offerings
7.4.4 ForeSee Medical Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.4.5 ForeSee Medical Key News
7.5 Atomwise
7.5.1 Atomwise Corporate Summary
7.5.2 Atomwise Business Overview
7.5.3 Atomwise Artificial Intelligence in Medical Major Product Offerings
7.5.4 Atomwise Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.5.5 Atomwise Key News
7.6 Cloud Pharmaceuticals
7.6.1 Cloud Pharmaceuticals Corporate Summary
7.6.2 Cloud Pharmaceuticals Business Overview
7.6.3 Cloud Pharmaceuticals Artificial Intelligence in Medical Major Product Offerings
7.6.4 Cloud Pharmaceuticals Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.6.5 Cloud Pharmaceuticals Key News
7.7 GNS Healthcare
7.7.1 GNS Healthcare Corporate Summary
7.7.2 GNS Healthcare Business Overview
7.7.3 GNS Healthcare Artificial Intelligence in Medical Major Product Offerings
7.7.4 GNS Healthcare Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.7.5 GNS Healthcare Key News
7.8 Microsoft Corporation
7.8.1 Microsoft Corporation Corporate Summary
7.8.2 Microsoft Corporation Business Overview
7.8.3 Microsoft Corporation Artificial Intelligence in Medical Major Product Offerings
7.8.4 Microsoft Corporation Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.8.5 Microsoft Corporation Key News
7.9 Novartis AG
7.9.1 Novartis AG Corporate Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Artificial Intelligence in Medical Major Product Offerings
7.9.4 Novartis AG Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.9.5 Novartis AG Key News
7.10 NVIDIA Corporation
7.10.1 NVIDIA Corporation Corporate Summary
7.10.2 NVIDIA Corporation Business Overview
7.10.3 NVIDIA Corporation Artificial Intelligence in Medical Major Product Offerings
7.10.4 NVIDIA Corporation Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.10.5 NVIDIA Corporation Key News
7.11 Pfizer
7.11.1 Pfizer Corporate Summary
7.11.2 Pfizer Business Overview
7.11.3 Pfizer Artificial Intelligence in Medical Major Product Offerings
7.11.4 Pfizer Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.11.5 Pfizer Key News
7.12 Recursion Pharmaceuticals
7.12.1 Recursion Pharmaceuticals Corporate Summary
7.12.2 Recursion Pharmaceuticals Business Overview
7.12.3 Recursion Pharmaceuticals Artificial Intelligence in Medical Major Product Offerings
7.12.4 Recursion Pharmaceuticals Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.12.5 Recursion Pharmaceuticals Key News
7.13 XtalPi Inc
7.13.1 XtalPi Inc Corporate Summary
7.13.2 XtalPi Inc Business Overview
7.13.3 XtalPi Inc Artificial Intelligence in Medical Major Product Offerings
7.13.4 XtalPi Inc Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.13.5 XtalPi Inc Key News
7.14 Aidoc
7.14.1 Aidoc Corporate Summary
7.14.2 Aidoc Business Overview
7.14.3 Aidoc Artificial Intelligence in Medical Major Product Offerings
7.14.4 Aidoc Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.14.5 Aidoc Key News
7.15 AliveCor
7.15.1 AliveCor Corporate Summary
7.15.2 AliveCor Business Overview
7.15.3 AliveCor Artificial Intelligence in Medical Major Product Offerings
7.15.4 AliveCor Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.15.5 AliveCor Key News
7.16 GE Healthcare
7.16.1 GE Healthcare Corporate Summary
7.16.2 GE Healthcare Business Overview
7.16.3 GE Healthcare Artificial Intelligence in Medical Major Product Offerings
7.16.4 GE Healthcare Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.16.5 GE Healthcare Key News
7.17 Imagen Technologies
7.17.1 Imagen Technologies Corporate Summary
7.17.2 Imagen Technologies Business Overview
7.17.3 Imagen Technologies Artificial Intelligence in Medical Major Product Offerings
7.17.4 Imagen Technologies Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.17.5 Imagen Technologies Key News
7.18 Vuno Inc.
7.18.1 Vuno Inc. Corporate Summary
7.18.2 Vuno Inc. Business Overview
7.18.3 Vuno Inc. Artificial Intelligence in Medical Major Product Offerings
7.18.4 Vuno Inc. Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.18.5 Vuno Inc. Key News
7.19 IDx Technologies Inc.
7.19.1 IDx Technologies Inc. Corporate Summary
7.19.2 IDx Technologies Inc. Business Overview
7.19.3 IDx Technologies Inc. Artificial Intelligence in Medical Major Product Offerings
7.19.4 IDx Technologies Inc. Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.19.5 IDx Technologies Inc. Key News
7.20 Siemens Healthcare GmbH
7.20.1 Siemens Healthcare GmbH Corporate Summary
7.20.2 Siemens Healthcare GmbH Business Overview
7.20.3 Siemens Healthcare GmbH Artificial Intelligence in Medical Major Product Offerings
7.20.4 Siemens Healthcare GmbH Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.20.5 Siemens Healthcare GmbH Key News
7.21 Neural Analytics
7.21.1 Neural Analytics Corporate Summary
7.21.2 Neural Analytics Business Overview
7.21.3 Neural Analytics Artificial Intelligence in Medical Major Product Offerings
7.21.4 Neural Analytics Artificial Intelligence in Medical Revenue in Global Market (2017-2022)
7.21.5 Neural Analytics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Artificial Intelligence in Medical Market Opportunities & Trends in Global Market
Table 2. Artificial Intelligence in Medical Market Drivers in Global Market
Table 3. Artificial Intelligence in Medical Market Restraints in Global Market
Table 4. Key Players of Artificial Intelligence in Medical in Global Market
Table 5. Top Artificial Intelligence in Medical Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Artificial Intelligence in Medical Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Artificial Intelligence in Medical Revenue Share by Companies, 2017-2022
Table 8. Global Companies Artificial Intelligence in Medical Product Type
Table 9. List of Global Tier 1 Artificial Intelligence in Medical Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Artificial Intelligence in Medical Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Artificial Intelligence in Medical Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Artificial Intelligence in Medical Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Artificial Intelligence in Medical Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Artificial Intelligence in Medical Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Artificial Intelligence in Medical Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Artificial Intelligence in Medical Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Artificial Intelligence in Medical Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Artificial Intelligence in Medical Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Artificial Intelligence in Medical Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Artificial Intelligence in Medical Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Artificial Intelligence in Medical Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Artificial Intelligence in Medical Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Artificial Intelligence in Medical Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Artificial Intelligence in Medical Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Artificial Intelligence in Medical Product Offerings
Table 32. AstraZeneca Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 33. Thales Group Corporate Summary
Table 34. Thales Group Artificial Intelligence in Medical Product Offerings
Table 35. Thales Group Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 36. IBM Corp. Corporate Summary
Table 37. IBM Corp. Artificial Intelligence in Medical Product Offerings
Table 38. IBM Corp. Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 39. ForeSee Medical Corporate Summary
Table 40. ForeSee Medical Artificial Intelligence in Medical Product Offerings
Table 41. ForeSee Medical Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 42. Atomwise Corporate Summary
Table 43. Atomwise Artificial Intelligence in Medical Product Offerings
Table 44. Atomwise Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 45. Cloud Pharmaceuticals Corporate Summary
Table 46. Cloud Pharmaceuticals Artificial Intelligence in Medical Product Offerings
Table 47. Cloud Pharmaceuticals Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 48. GNS Healthcare Corporate Summary
Table 49. GNS Healthcare Artificial Intelligence in Medical Product Offerings
Table 50. GNS Healthcare Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 51. Microsoft Corporation Corporate Summary
Table 52. Microsoft Corporation Artificial Intelligence in Medical Product Offerings
Table 53. Microsoft Corporation Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 54. Novartis AG Corporate Summary
Table 55. Novartis AG Artificial Intelligence in Medical Product Offerings
Table 56. Novartis AG Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 57. NVIDIA Corporation Corporate Summary
Table 58. NVIDIA Corporation Artificial Intelligence in Medical Product Offerings
Table 59. NVIDIA Corporation Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 60. Pfizer Corporate Summary
Table 61. Pfizer Artificial Intelligence in Medical Product Offerings
Table 62. Pfizer Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 63. Recursion Pharmaceuticals Corporate Summary
Table 64. Recursion Pharmaceuticals Artificial Intelligence in Medical Product Offerings
Table 65. Recursion Pharmaceuticals Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 66. XtalPi Inc Corporate Summary
Table 67. XtalPi Inc Artificial Intelligence in Medical Product Offerings
Table 68. XtalPi Inc Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 69. Aidoc Corporate Summary
Table 70. Aidoc Artificial Intelligence in Medical Product Offerings
Table 71. Aidoc Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 72. AliveCor Corporate Summary
Table 73. AliveCor Artificial Intelligence in Medical Product Offerings
Table 74. AliveCor Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 75. GE Healthcare Corporate Summary
Table 76. GE Healthcare Artificial Intelligence in Medical Product Offerings
Table 77. GE Healthcare Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 78. Imagen Technologies Corporate Summary
Table 79. Imagen Technologies Artificial Intelligence in Medical Product Offerings
Table 80. Imagen Technologies Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 81. Vuno Inc. Corporate Summary
Table 82. Vuno Inc. Artificial Intelligence in Medical Product Offerings
Table 83. Vuno Inc. Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 84. IDx Technologies Inc. Corporate Summary
Table 85. IDx Technologies Inc. Artificial Intelligence in Medical Product Offerings
Table 86. IDx Technologies Inc. Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 87. Siemens Healthcare GmbH Corporate Summary
Table 88. Siemens Healthcare GmbH Artificial Intelligence in Medical Product Offerings
Table 89. Siemens Healthcare GmbH Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
Table 90. Neural Analytics Corporate Summary
Table 91. Neural Analytics Artificial Intelligence in Medical Product Offerings
Table 92. Neural Analytics Artificial Intelligence in Medical Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Artificial Intelligence in Medical Segment by Type in 2021
Figure 2. Artificial Intelligence in Medical Segment by Application in 2021
Figure 3. Global Artificial Intelligence in Medical Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Artificial Intelligence in Medical Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Artificial Intelligence in Medical Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Artificial Intelligence in Medical Revenue in 2021
Figure 8. By Type - Global Artificial Intelligence in Medical Revenue Market Share, 2017-2028
Figure 9. By Application - Global Artificial Intelligence in Medical Revenue Market Share, 2017-2028
Figure 10. By Region - Global Artificial Intelligence in Medical Revenue Market Share, 2017-2028
Figure 11. By Country - North America Artificial Intelligence in Medical Revenue Market Share, 2017-2028
Figure 12. US Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Artificial Intelligence in Medical Revenue Market Share, 2017-2028
Figure 16. Germany Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 17. France Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Artificial Intelligence in Medical Revenue Market Share, 2017-2028
Figure 24. China Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 28. India Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Artificial Intelligence in Medical Revenue Market Share, 2017-2028
Figure 30. Brazil Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Artificial Intelligence in Medical Revenue Market Share, 2017-2028
Figure 33. Turkey Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Artificial Intelligence in Medical Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Thales Group Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. IBM Corp. Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. ForeSee Medical Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Atomwise Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cloud Pharmaceuticals Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GNS Healthcare Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Microsoft Corporation Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Novartis AG Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. NVIDIA Corporation Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Pfizer Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Recursion Pharmaceuticals Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. XtalPi Inc Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Aidoc Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. AliveCor Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. GE Healthcare Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Imagen Technologies Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Vuno Inc. Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. IDx Technologies Inc. Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Siemens Healthcare GmbH Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Neural Analytics Artificial Intelligence in Medical Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|